Trousseau's syndrome: multiple definitions and multiple mechanisms.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Blood

• Publication date

  2007-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-10-053736PMID 17496204PMCID PMC1976377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thrombosis as a harbinger of cancer

  2006cited by this paper
• The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology

  2006cited by this paper
• The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo

  2006cited by this paper
• Tissue factor in cancer and angiogenesis: the molecular link between genetic tumor progression, tumor neovascularization, and cancer coagulopathy.

  2006cited by this paper
• Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"?

  2006cited by this paper
• Mechanisms of Cancer-Induced Thrombosis in Cancer

  2006cited by this paper
• Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans.

  2006cited by this paper
• Hypercoagulability preceding cancer

  2005cited by this paper
• Hypercoagulability preceding cancer

  2005cited by this paper
• The MET oncogene drives a genetic programme linking cancer to haemostasis

  2005cited by this paper
• A functional role for hemostasis in early cancer development.

  2005cited by this paper
• Hypercoagulability preceding cancer

  2005cited by this paper
• Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis.

  2005cited by this paper
• Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism.

  2005cited by this paper
• Differential Metastasis Inhibition by Clinically Relevant Levels of Heparins—Correlation with Selectin Inhibition, Not Antithrombotic Activity

  2005cited by this paper
• Venous thrombosis in inflammatory bowel disease

  2005cited by this paper
• Hypercoagulability preceding cancer. Does hypercoagulability awaken dormant tumor cells in the host?

  2005cited by this paper
• Hypercoagulability preceding cancer. The iron hypothesis.

  2005cited by this paper
• The P‐selectin, tissue factor, coagulation triad

  2005cited by this paper
• Cancer procoagulant in patients with adenocarcinomas

  2005cited by this paper
• Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies.

  2004cited by this paper
• [Treatment of venous thromboembolism in cancer patients].

  2004cited by this paper
• Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial

  2004cited by this paper
• Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

  2004cited by this paper
• Low-molecular-weight heparin in thrombosis and cancer.

  2004cited by this paper
• The prothrombotic state in cancer: pathogenic mechanisms.

  2004cited by this paper
• The heparins and cancer: review of clinical trials and biological properties

  2004cited by this paper
• Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway

  2004cited by this paper
• Malignancy, thrombosis and Trousseau: the case for an eponym

  2003cited by this paper
• Low-molecular-weight heparin in oncology.

  2003cited by this paper
• Non-Anticoagulant Effects of Heparin inCarcinoma Metastasis and Trousseau’s Syndrome

  2003cited by this paper
• Thromboembolic complications of cancer: Epidemiology, pathogenesis, diagnosis, and treatment

  2003cited by this paper
• Heparin, low-molecular-weight heparins, and heparin pentasaccharide: basic and clinical differentiation.

  2003cited by this paper
• The Impact of Heparin Compounds on Cellular Inflammatory Responses: A Construct for Future Investigation and Pharmaceutical Development

  2003cited by this paper
• Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas.

  2003cited by this paper
• Changes in Bone Density during Long-Term Administration of Low-Molecular-Weight Heparins or Acenocoumarol for Secondary Prophylaxis of Venous Thromboembolism

  2003cited by this paper
• Cancer and thromboembolic disease: pathogenic mechanisms.

  2002cited by this paper
• Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis

  2002cited by this paper
• Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

  2002cited by this paper
• Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer.

  2002cited by this paper
• Cancer and the prothrombotic state.

  2002cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2002. A 61-year-old man with headache and multiple infarcts.

  2002cited by this paper
• Heparin-protein interactions.

  2002cited by this paper
• Heparin Inhibition of Selectin-Mediated Interactions during the Hematogenous Phase of Carcinoma Metastasis: Rationale for Clinical Studies in Humans

  2002cited by this paper
• Synthesis and secretion of Muc4/sialomucin complex: implication of intracellular proteolysis.

  2002cited by this paper
• Therapeutic Equivalency of Low-Molecular-Weight Heparins

  2002cited by this paper
• Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis.

  2001cited by this paper
• Order out of complexity--protein structures that interact with heparin.

  2001cited by this paper
• Molecular Cloning of the CA125 Ovarian Cancer Antigen

  2001cited by this paper
• Molecular Weight-Dependent Influence of Heparin on the Form of Tissue Factor Pathway Inhibitor Circulating in Plasma

  2001cited by this paper
• Molecular diversity of heparan sulfate.

  2001cited by this paper
• Heparin and cancer revisited: Mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis

  2001cited by this paper
• Molecular basis for the relationship between thrombosis and cancer.

  2001cited by this paper
• MUC1: the polymorphic appearance of a human mucin.

  2000cited by this paper
• Tissue Factor on the Loose

  2000cited by this paper
• The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation.

  2000cited by this paper
• Physiological Function of Tissue Factor Pathway Inhibitor and Interaction with Heparins

  2000cited by this paper
• Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

  2000cited by this paper
• Mucin-type O-glycans and leukosialin.

  1999cited by this paper
• Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

  1999cited by this paper
• Production and chemical processing of low molecular weight heparins.

  1999cited by this paper
• Markedly elevated CA125 in hepatic cirrhosis: two case illustrations and review of the literature.

  1999cited by this paper
• The Structure and Assembly of Secreted Mucins* 210

  1999cited by this paper
• Usefulness of novel tumour markers.

  1999cited by this paper
• Pharmacokinetic and Pharmacodynamic Properties of Oral Anticoagulants, Especially Phenprocoumon

  1999cited by this paper
• Treatment of Venous Thromboembolism in Cancer Patients

  1999cited by this paper
• What Else Can ‘Heparin’ Do?

  1999cited by this paper
• Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

  1998cited by this paper
• Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy.

  1998cited by this paper
• Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents.

  1998cited by this paper
• Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism

  1998cited by this paper
• Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitor.

  1998cited by this paper
• P-selectin deficiency attenuates tumor growth and metastasis.

  1998cited by this paper
• Structural requirements of human tissue factor pathway inhibitor (TFPI) and heparin for TFPI-heparin interaction.

  1998cited by this paper
• Subcutaneous low-molecular-weight heparin for treatment of Trousseau’s syndrome

  1997cited by this paper
• Low‐molecular‐weight heparin in the management of Tyrousseau's syndrome

  1997cited by this paper
• Prospective study of CAM 17.1/WGA mucin assay for serological diagnosis of pancreatic cancer.

  1997cited by this paper
• P-selectin induction of tissue factor biosynthesis and expression.

  1996cited by this paper
• Coagulation disorders in cancer.

  1996cited by this paper
• Mucin glycoproteins in neoplasia

  1996cited by this paper
• Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl‐Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL‐60 leukocyte adhesion to E‐selectin‐expressing endothelial cells

  1996cited by this paper
• Endothelial Heparan Sulfate Proteoglycans That Bind to L-Selectin Have Glucosamine Residues with Unsubstituted Amino Groups (*)

  1995cited by this paper
• Continuous Subcutaneous Heparin Infusion for Treatment of Trousseau's Syndrome

  1995cited by this paper
• Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer.

  1995cited by this paper
• Coagulopathies of liver disease.

  1994cited by this paper
• Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation.

  1993cited by this paper
• Trousseau's syndrome.

  1993cited by this paper
• Calcium-dependent heparin-like ligands for L-selectin in nonlymphoid endothelial cells.

  1993cited by this paper
• Inflammatory roles of P-selectin.

  1993cited by this paper
• Molecular Interactions Between Heparin Cofactor II and Thrombin

  1992cited by this paper
• Immunohistochemical identification of tissue factor in solid tumors

  1992cited by this paper
• Tissue factor as a tumor procoagulant

  1992cited by this paper
• Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation.

  1992cited by this paper
• Tissue factor pathway inhibitor and heparin.

  1992cited by this paper
• Drug therapy : heparin

  1991cited by this paper
• Preparation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2.

  1991cited by this paper
• Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin.

  1991cited by this paper
• Case records of the Massachusetts General Hospital.

  1990cited by this paper
• Profiles of Lewisx-containing glycoproteins and glycolipids in sera of patients with adenocarcinoma.

  1990cited by this paper
• Weekly clinicopathological exercises

  1990cited by this paper

• Superficial Venous Thrombosis in Non-Varicose Veins: A Narrative Review

  2026cites this paper
• Rare Case of Internal Jugular Vein Thrombosis Associated With Squamous Cell Carcinoma of the Posterior Tongue.

  2026cites this paper
• Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter study.

  2026cites this paper
• A Dynamic Multimodality Imaging Assessment of Right Ventricular Thrombosis in a Middle-Aged Man with Lymphocytic Interstitial Pneumonia: The Additive Role of Tissue Doppler Imaging

  2025cites this paper
• Ischemic stroke in patients with unresectable pancreatic and gastric cancer

  2025cites this paper
• Hypercoagulation after neoadjuvant immunochemotherapy as a new prognostic indicator in patients with locally advanced gastric cancer undergoing surgery

  2025cites this paper
• Floating Thrombus on the Ascending Aorta and/or Aortic Arch, to Operate or Not to Operate: Two Case Reports and a Literature Review

  2025cites this paper
• Misdiagnosis of Metastatic Thymoma Presenting with Deep Vein Thrombosis and Intra-cardiac Thrombus as Non-Hodgkin’s Lymphoma in an Adolescent: A Case Report

  2025cites this paper
• Unusual Manifestations of Primary Pancreatic Neoplasia

  2025cites this paper
• Clot formation, structure, and fibrinolysis of plasma from pancreatic cancer patients

  2025cites this paper
• Cancer-associated venous thromboembolism: a comprehensive review

  2025cites this paper
• Integrated Management of Stroke Risk in Brain Cancer: Insights from the Tumoral Bleeding Classification System and CanStroke Protocol

  2025cites this paper
• Review of Trousseau phenomenon - pathomechanism, diagnosis, treatment and risk of cancer

  2025cites this paper
• Perioperative inflammatory index differences between pulmonary squamous cell carcinoma and adenocarcinoma and their prognostic implications

  2025cites this paper
• Home Intravenous Heparin Therapy via a Central Venous Port for Recurrent Cancer-Associated Stroke Requiring Repeat Mechanical Thrombectomy: A Case Report.

  2025cites this paper
• Perioperative Management of a Case of Trousseau Syndrome Accompanied by Aortic Valve Vegetation

  2025cites this paper
• Incidence and risk factors for ischemic stroke in patients with cancer: A retrospective observational study.

  2025cites this paper
• Immune cell changes following chemotherapy in advanced pancreatic cancer with variations based on gender

  2025cites this paper
• Paraneoplastic syndromes in ovarian cancer: Clinical manifestations, mechanisms and management challenges.

  2025cites this paper
• Trousseau’s Syndrome and Marantic Endocarditis in a Patient with Pulmonary Adenocarcinoma: A Case Report and a Brief Review of the Literature

  2025cites this paper
• Clear Cell Ovarian Carcinoma and Its Distinct Coagulopathy Profile: Molecular Drivers and Clinical Implications

  2025cites this paper
• Primary and secondary metastatic dissemination: multiple routes to cancer-related death

  2025cites this paper
• Sudden Death Due to Hypercoagulability in a Patient With Pancreatic Cancer and Diabetic Ketoacidosis

  2025cites this paper
• A Novel Series of Synthetic Heparin‐Mimetics–Itaconic Acid‐Containing Copolymers for Targeting Tumor Cell Coagulability and Metastasis

  2025cites this paper
• Evaluation of Coagulation and Fibrinolysis Mechanisms in Deep Vein Thrombosis Using Clot‐Fibrinolysis Waveform Analysis

  2025cites this paper
• Features of clinical manifestations of ischemic stroke in cancer

  2025cites this paper
• Surface‐Anchored Ticagrelor Gelatin Nanoparticles‐Platelets System for Enhanced Anti‐PD‐L1 Therapy Response and Boosted Chemotherapeutic Efficacy of Nanomedicines

  2025cites this paper
• Clot formation, structure, and fibrinolysis of pancreatic cancer patients

  2025cites this paper
• Trousseau Syndrome-Associated Acute Multifocal Cerebral Infarction: When Triple-Pathway Antithrombotic Therapy Overcomes Low Molecular Weight Heparin Resistance

  2025cites this paper
• Clinical outcomes of cancer-associated isolated distal deep vein thrombosis: a comparison between asymptomatic and symptomatic thrombosis—findings from the ONCO DVT Study

  2025cites this paper
• Thrombus formation in cancer patients using autopsy materials: an immunohistochemical analysis.

  2025cites this paper
• Activation of the Coagulation Cascade as a Universal Danger Sign

  2025cites this paper
• Aggressive Bladder Urothelial Carcinoma in an HIV‐Positive Male With Neurogenic Bladder Dysfunction due to Spina Bifida: An Autopsy Case

  2025cites this paper
• Ischemic stroke associated with adenomyosis-related abnormal uterine bleeding: a systematic review of management and outcomes

  2025cites this paper
• Superficial Vein Thrombosis.

  2025cites this paper
• Long-term bleeding events post-percutaneous coronary intervention in patients with malignancy with and without anticoagulant therapy

  2025cites this paper
• Cancer-Associated Thrombosis, With a Focus on Ischemic Heart Disease.

  2025cites this paper
• Spontaneous upper extremity deep vein thrombosis as initial manifestation of a malignant mediastinal teratoma

  2025cites this paper
• Bilateral Ovarian Vein Thrombosis in a Post-menopausal Woman Leading to Diagnosis of Non-gynecological Malignancy: A Case Report

  2025cites this paper
• Cerebral infarction associated with adenomyosis: Two case reports with mechanistic insights and multidisciplinary management

  2025cites this paper
• Venous Manifestations of Gastric Cancer: Bilateral Varicose Veins as a Rare Initial Presentation—A Narrative Review

  2025influential citation
• Network Controllability Reveals Key Mitigation Points for Tumor-Promoting Signaling in Tumor-Educated Platelets

  2025cites this paper
• [Embolic occlusions of the right hand: an interdisciplinary challenge].

  2025cites this paper
• Natural, Engineered, and Hybrid Platelet Membrane–Based Nanotherapeutics for Inflammatory Diseases

  2025cites this paper
• Incidence and predictors of acute pulmonary embolism in patients with cancer referred for computed tomography pulmonary angiography

  2025cites this paper
• 68Ga-FAPI PET/CT for preoperative evaluation of trousseau syndrome: A case report

  2025cites this paper
• Acute Concurrent Cardiocerebral Infarction Associated With Trousseau Syndrome: A Case Report

  2025cites this paper
• Manejo avanzado de las complicaciones tromboembólicas en los pacientes con tumores sólidos y hematológicos

  2025cites this paper
• Three-territory infarct in Trousseau syndrome: A case series and review of literature

  2025cites this paper
• Interplay of genetic and clinical factors in cancer-associated thrombosis: Deciphering the prothrombotic landscape of colorectal cancer

  2025cites this paper
• A Case of Trousseau Syndrome: A Report Detailing Recurrent Ischaemic Strokes Associated With Metastatic Pancreatic Cancer and Pulmonary Embolisms Despite Treatment With Direct Oral Anticoagulation

  2025cites this paper
• When Cancer Clouds the Picture of Arterial Embolism Masquerading as Spinal Cord Compression in a Man With Metastatic Prostate Cancer

  2025cites this paper
• Unveiling the “Dark Matter” of platelet involvement in tumor microenvironment

  2025cites this paper
• Retinal vascular occlusion as presenting sign of occult gynecological cancer.

  2025cites this paper
• Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms

  2025influential citation
• Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort study

  2024cites this paper
• Revisiting the meaning of Trousseau sign and syndrome

  2024cites this paper
• Clinical guidelines for prevention and treatment of CAT in Japan and other countries

  2024cites this paper
• Malignancy‐associated ischemic stroke: Implications for diagnostic and therapeutic workup

  2024cites this paper
• Updated review on malignancy-associated venous thromboembolism: Pathogenesis and comparison between various therapeutic modalities

  2024cites this paper
• A case of Trousseau syndrome: Screening, detection and complication

  2024cites this paper
• Prevention and Treatment of Thrombotic Complications in Cancer Patients

  2024cites this paper
• A Single-Center Experience of Mechanical Thrombectomy for Cancer-Associated Ischemic Stroke

  2024cites this paper
• Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling—New Cues on CAT-VTE

  2024cites this paper
• Consequences of platelet-educated cancer cells on the expression of inflammatory and metastatic glycoproteins

  2024cites this paper
• Lung Adenocarcinoma with Trousseau's Syndrome That Could be Controlled for a Long Time with Heparin Subcutaneous Injection and Edoxaban: a Case Report

  2024cites this paper
• Clinical features and prognostic factors of patients with cancer-associated stroke

  2024cites this paper
• Multimodality Imaging Supports Cardiac Lesion Diagnosis in Patient With Liver Carcinoma: A Case Report

  2024cites this paper
• Trousseau syndrome-induced cerebral infarction: Two case reports

  2024cites this paper
• Trousseau’s Syndrome: A Case Report and Literature Review

  2024cites this paper
• Synchronous Pulmonary Arterial and Pulmonary Venous Thrombosis in Pancreatic Cancer.

  2024cites this paper
• What lies beneath a deep vein thrombosis.

  2024cites this paper
• Platelet proteomics: Clinical implications - Decoding the black box!

  2024cites this paper
• Incidence and risk factors of ischemic stroke in patients with cancer-associated venous thromboembolism: from the Contemporary Management and Outcomes in Patients With Venous Thromboembolism Registry-2

  2024cites this paper
• Clinical features and predictors of early neurological deterioration in patients with Trousseau syndrome-related cerebral infarction

  2024cites this paper
• Genetic Evidence for the Causal Link Between Coagulation Factors and the Risk of Ovarian Cancer: A Two-Sample Mendelian Randomization Study

  2024cites this paper
• Overview and Future Direction of Embolic Stroke of Undetermined Source from the Insights of CHALLENGE ESUS/CS Registry

  2024cites this paper
• Cerebral infarction caused by Trousseau syndrome associated with cervical cancer

  2024influential citation
• Impact of MASLD on Portal Vein Thrombosis Following Hepatectomy for Liver Cancer

  2024cites this paper
• Cutaneous Signs of Internal Malignancy

  2024cites this paper
• Trousseau’s Syndrome in Lung Cancer Patients: A Retrospective Study in a Japanese Community Hospital

  2024cites this paper
• Trousseau's Syndrome: A Paraneoplastic Complication.

  2024cites this paper
• Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients

  2024cites this paper
• Deep venous thrombosis, as the earliest presenting feature of gallbladder carcinoma: Case report

  2024cites this paper
• Treatment and Clinical Features in Patients with Lung Cancer Complicated by Trousseau’s Syndrome

  2024cites this paper
• Exploring the Complexities of Non-Bacterial Thrombotic Endocarditis: Highlights from Literature and Case Studies

  2024cites this paper
• Comorbid thrombosis as an adverse prognostic factor in patients with ovarian clear cell carcinoma regardless of staging

  2024cites this paper
• Interpretation of the Pathological Mechanism of Blood Stasis in Traditional Chinese Medicine in Light of Understanding of Hypercoagulable States in Modern Medicine

  2024cites this paper
• Beyond One-size-fits-all: Personalised ‘Tailored’ Approaches to Embolic Stroke of Undetermined Source

  2024cites this paper
• Advanced epithelioid haemangioendothelioma in a child presenting as deep vein thrombosis

  2024cites this paper
• Underlying Mechanisms of Thrombosis Associated with Cancer and Anticancer Therapies

  2024cites this paper
• Clinical and radiological differentiation between Trousseau syndrome and cardiogenic embolism: a retrospective case-control study

  2024cites this paper
• Absence of the Susceptibility Vessel Sign with Cancer-Associated Hypercoagulability-Related Stroke

  2024cites this paper
• Trousseau syndrome with recurrent cerebral infarction as the first oneset in a gastrointestinal malignant tumor patient: A case report

  2024cites this paper
• Central retinal vein occlusion in patients with metastatic solid tumors on tyrosine kinase inhibitors: a report of case series and literature review

  2024cites this paper
• Lumbrokinase Extracted from Earthworms Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling

  2024cites this paper
• Absence of Hypercoagulation Status after Neoadjuvant Treatment is Associated with Favorable Prognosis in Patients Undergoing Subtotal Esophagectomy for Esophageal Squamous Cell Carcinoma

  2024cites this paper
• Cerebral infarction with severe iron deficiency anemia due to uterine leiomyoma: a case report

  2024cites this paper
• Association between the controlling nutritional status score and outcomes in ischemic stroke patients with active cancer.

  2024cites this paper
• Complication Rates of Peripherally Inserted Central Catheters in Oncologic Versus Non-Oncologic Patients.

  2024cites this paper